Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Sep;59(9):2233-2235.
doi: 10.1002/ppul.27025. Epub 2024 Apr 23.

Clinical and research innovations in childhood interstitial lung disease (chILD)

Jennifer A Wambach  1 , Timothy J Vece  2
Affiliations
Editorial

Clinical and research innovations in childhood interstitial lung disease (chILD)

Jennifer A Wambach et al. Pediatr Pulmonol. 2024 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest Statement:

Dr. Wambach received consulting fees from Simumetrix to develop continuing medication education (CME) content related to childhood interstitial lung disease. Dr. Vece received consulting fees from Boehringer Ingelheim

References

    1. Kurland G, Deterding RR, Hagood JS, et al. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med 2013;188(3):376–94. DOI: 10.1164/rccm.201305-0923ST. - DOI - PMC - PubMed
    1. Nevel RJ, Deutsch GH, Craven D, et al. The US national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort. Pediatr Pulmonol 2023. DOI: 10.1002/ppul.26568. - DOI - PMC - PubMed
    1. Griese M, Seidl E, Hengst M, et al. International management platform for children’s interstitial lung disease (chILD-EU). Thorax 2018;73(3):231–239. DOI: 10.1136/thoraxjnl-2017-210519. - DOI - PubMed
    1. Temple SEL, Ho G, Bennetts B, et al. The role of exome sequencing in childhood interstitial or diffuse lung disease. Orphanet J Rare Dis 2022;17(1):350. DOI: 10.1186/s13023-022-02508-1. - DOI - PMC - PubMed
    1. Griese M, Kappler M, Stehling F, et al. Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease. Orphanet J Rare Dis 2022;17(1):289. DOI: 10.1186/s13023-022-02399-2. - DOI - PMC - PubMed

Publication types